Additionally, treatment with a phosphatidylinositol 3-kinase inhibitor (LY294002) decreased PLOD2 expression in MDA-MB-231 and MDA-MB-468 breast cancer cells (Fig. 6c, Additional file 5: Figure S4c). The gene discussed is PLOD2; the disease is breast carcinoma.